Failing a drug test definition

Failing a drug test means confirmation of an initial test result which that shows a detectable level of an illegal drug, unauthorized controlled substance, drug metabolite or alcohol in the body.
Sample 1Sample 2Sample 3
Failing a drug test means the test results show positive evidence of the presence of a drug or drug metabolite in an employee’s system in amounts that exceed cutoff levels established by this policy.
Sample 1
Failing a drug test means the test results show positive evidence of the presence of a drug or drugmetabolite in an employee’s system.
Sample 1

Examples of Failing a drug test in a sentence

  • Failing a drug test will result in consequences according to the SISD Drug Testing Policy.

  • Failing a Drug Test Failing a drug test shall mean that the test results show positive evidence of the presence of a prohibitive drug or drug metabolite in an employee’s system in amounts that exceed cutoff levels.

  • Failing a drug test during the divorce proceedings can pretty much preclude you from getting physical custody.

  • Failing a drug test due to the unauthorized use of alcohol or other controlled substances.

  • This list is not exhaustive.• Failing a drug test, required by a University program or activity, including drug tests required by co-op employers or clinical placements, may be considered a violation of this policy.Students and Student Organizations should familiarize themselves with the Responsible Dragon Amnesty Policy (RDAP) at the beginning of Section 5 and how amnesty of this policy can apply if conditions are met during a medical emergency.

  • Failing a drug test due to having an illegal substance in your system.

  • This list is not exhaustive.• Failing a drug test, required by a University program or activity, may be considered a violation of this policy.Students and Student Organizations should familiarize themselves with the Responsible Dragon Amnesty Policy (RDAP) at the beginning of Section 5 and how amnesty of this policy can apply if conditions are met during a medical emergency.

  • Failing a drug test will result in disciplinary actions, up to and including termination.• Arrive at the medical facility in a timely fashion.• All employees filing a claim that need medical treatment must be accompanied to the physician’s office by a supervisor.• Present the Authorization Form to the receptionist.• Return appropriate medical treatment forms to your supervisor.• Keep all appointments for on-going medical care and assist the City in the treatment of injury or illness.

  • Failing a drug test will result in the consequence for the next offense.

  • Failing a Drug Test -­‐ Failing a drug test shall mean that the test results show positive evidence of the presence of a prohibitive drug or drug metabolite in an employee's system in amounts that exceed cutoff levels.

Related to Failing a drug test

  • Drug test means a test designed to detect the illegal use of a controlled substance.

  • Drug use test means a scientifically substantiated method to test for the presence of illegal or performance-enhancing drugs or the metabolites thereof in a person’s urine.

  • Drug abuse means any pattern of pathological use of drugs that causes impairment in social or occupational functioning, or that produces physiological dependency evidenced by physical tolerance or by physical symptoms when it is withdrawn.

  • Drug addiction means a disease characterized by a

  • Phase III Clinical Trial means a large, controlled or uncontrolled Clinical Study that would satisfy the requirements of 21 CFR 312.21(c), intended to gather the additional information about effectiveness and safety that is needed to evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling.

  • New Drug Application means a new drug application in the United States for authorization to market a product, as defined in the applicable laws and regulations and submitted to the FDA.

  • Phase III Clinical Study means a human clinical study of a product on a sufficient number of subjects that is designed to establish that such product is safe and efficacious for its intended use, and to determine warnings, precautions, and adverse reactions that are associated with such product in the dosage range to be prescribed, which trial is intended to support Regulatory Approval of such product, as described in 21 C.F.R. 312.21(c). 1.185. [***] 1.186. [***]

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Biologics License Application or “BLA” means an application requesting permission from the FDA to introduce, or deliver for introduction, a biological product into interstate commerce, or any similar application or submission for marketing authorization of a product filed with a Regulatory Authority to obtain Regulatory Approval for such product in a country or group of countries.

  • Phase IV Clinical Trial means a product support clinical trial of a Product commenced after receipt of Regulatory Approval in the country where such trial is conducted. A Phase IV Clinical Trial may include epidemiological studies, modeling and pharmacoeconomic studies, and investigator-sponsored clinical trials studying Product that are approved by BMS and that otherwise fit the foregoing definition.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Drug Approval Application means an application for Regulatory Approval of a Licensed Product as a pharmaceutical product in a country in the Territory.

  • Participating Clinical Laboratory means a Clinical Laboratory which has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.